Delivery Order SPE2DB24D2205-SPE2DB26FDSQR
- Not listed
- The Defense Logistics Agency awarded a $10,547.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to military healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $5,237.35 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This competitive, firm fixed-price delivery order is scheduled for completion by September 10, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with a ceiling value of $6,706.07. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999.00 prime vendor agreement through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a $5,041.46 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This is a firm fixed price, non-set-aside contract with a completion date of June 20, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $12,575.41 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This firm fixed-price delivery order, which is expected to be completed by September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award was made on a competitive basis with no...
- The Defense Logistics Agency awarded a $4,278.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injections. The contract, with an ultimate completion date of September 24, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This award was competitively awarded with no...
- The Defense Logistics Agency awarded a $2,504.70 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Zepbound 12.5 mg/0.5 ml pen injectors, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order was executed without a set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $42,647.15 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Zepbound 10 mg/0.5 ml pen injectors. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The products will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $1,143.87 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors. This is a firm fixed price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The order represents a child delivery order under a larger contract vehicle, enabling the pharmaceutical distributor to supply critical medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with a ceiling value of $1,644.54. This is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB26FDSQRDelivery Order
The Defense Logistics Agency awarded a $41,431.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract, which represents a child award under AmerisourceBergen's broader pharmaceutical supply agreement with DLA, specifies performance at the contractor's Conshohocken, Pennsylvania facility with an ultimate completion date of October 23, 2025. This delivery order was awarded through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal medical procurement requirements competitively. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal healthcare systems, including military and veteran medical programs. The award is issued under the company's $999.99 billion Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which runs through December 2026 and provides comprehensive global pharmaceutical support for military healthcare worldwide. This particular delivery order for Zepbound, a diabetes medication, exemplifies the company's role in supplying specialized pharmaceutical products across multiple therapeutic domains to support Defense Health Agency and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.4k | 10/22/25 |